2,3-dinor-thromboxane b2 has been researched along with Ischemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
FitzGerald, GA; Friesinger, GC; Maas, RL; Oates, JA; Roberts, LJ; Robertson, D; Robertson, RM | 1 |
Bachi, A; Chiabrando, C; Corada, M; Fanelli, R | 1 |
1 trial(s) available for 2,3-dinor-thromboxane b2 and Ischemia
Article | Year |
---|---|
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Arteries; Aspirin; Clinical Trials as Topic; Coronary Circulation; Coronary Vessels; Double-Blind Method; Female; Humans; Indomethacin; Ischemia; Male; Middle Aged; Recurrence; Thromboxane A2; Thromboxane B2; Thromboxanes; Time Factors; Veins | 1981 |
1 other study(ies) available for 2,3-dinor-thromboxane b2 and Ischemia
Article | Year |
---|---|
Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat.
Topics: Animals; Ischemia; Liver; Male; Mass Spectrometry; Rats; Rats, Sprague-Dawley; Reperfusion; Thromboxane B2; Thromboxanes | 1994 |